Lazard Analyst Ratings
Lazard Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
10/27/2023 | 58.06% | Morgan Stanley | $41 → $45 | Maintains | Overweight |
10/12/2023 | 44.01% | Morgan Stanley | $42 → $41 | Maintains | Overweight |
10/10/2023 | 75.62% | JMP Securities | $53 → $50 | Maintains | Market Outperform |
10/03/2023 | 12.4% | UBS | $37 → $32 | Maintains | Neutral |
09/26/2023 | 47.52% | Morgan Stanley | $44 → $42 | Maintains | Overweight |
09/19/2023 | 12.4% | Goldman Sachs | $37 → $32 | Downgrades | Neutral → Sell |
07/31/2023 | 29.96% | UBS | $32 → $37 | Maintains | Neutral |
07/14/2023 | 51.04% | Morgan Stanley | $43 → $43 | Reiterates | Overweight → Overweight |
07/13/2023 | — | Keefe, Bruyette & Woods | Upgrades | Underperform → Market Perform | |
07/12/2023 | 51.04% | Morgan Stanley | $36 → $43 | Upgrades | Equal-Weight → Overweight |
07/10/2023 | 86.16% | JMP Securities | → $53 | Reiterates | Market Outperform → Market Outperform |
07/03/2023 | — | Wolfe Research | Upgrades | Underperform → Peer Perform | |
05/22/2023 | 86.16% | JMP Securities | $53 → $53 | Reiterates | Market Outperform → Market Outperform |
05/01/2023 | 8.89% | Keefe, Bruyette & Woods | $34 → $31 | Maintains | Underperform |
04/12/2023 | 26.45% | Morgan Stanley | $29 → $36 | Upgrades | Underweight → Equal-Weight |
01/10/2023 | 86.16% | JMP Securities | $56 → $53 | Maintains | Market Outperform |
10/31/2022 | 1.86% | Morgan Stanley | $28 → $29 | Maintains | Underweight |
08/04/2022 | 26.45% | Goldman Sachs | $32 → $36 | Maintains | Neutral |
07/18/2022 | 5.37% | Morgan Stanley | $40 → $30 | Downgrades | Equal-Weight → Underweight |
07/13/2022 | 5.37% | Keefe, Bruyette & Woods | $38 → $30 | Downgrades | Market Perform → Underperform |
07/08/2022 | 54.55% | Piper Sandler | $45 → $44 | Maintains | Overweight |
04/07/2022 | 58.06% | Piper Sandler | $49 → $45 | Maintains | Overweight |
04/07/2022 | 96.7% | JMP Securities | $58 → $56 | Maintains | Market Outperform |
04/07/2022 | 36.99% | Wolfe Research | → $39 | Downgrades | Peer Perform → Underperform |
03/09/2022 | 82.65% | Piper Sandler | $62 → $52 | Maintains | Overweight |
03/08/2022 | 40.5% | Morgan Stanley | → $40 | Downgrades | Overweight → Equal-Weight |
02/04/2022 | 72.11% | Keefe, Bruyette & Woods | $52 → $49 | Downgrades | Outperform → Market Perform |
01/04/2022 | 51.04% | UBS | $47 → $43 | Maintains | Neutral |
12/08/2021 | 93.19% | Morgan Stanley | $61 → $55 | Maintains | Overweight |
10/01/2021 | 103.72% | Keefe, Bruyette & Woods | $53 → $58 | Upgrades | Market Perform → Outperform |
05/03/2021 | 72.11% | Credit Suisse | $50 → $49 | Maintains | Neutral |
04/12/2021 | 75.62% | Credit Suisse | $49 → $50 | Maintains | Neutral |
04/07/2021 | 114.26% | Morgan Stanley | → $61 | Upgrades | Equal-Weight → Overweight |
01/14/2021 | 75.62% | Keefe, Bruyette & Woods | → $50 | Downgrades | Outperform → Market Perform |
12/16/2020 | 72.11% | Seaport Global | → $49 | Initiates Coverage On | → Buy |
12/14/2020 | 82.65% | Morgan Stanley | $39 → $52 | Upgrades | Underweight → Equal-Weight |
10/12/2020 | 36.99% | Morgan Stanley | $29 → $39 | Maintains | Underweight |
10/09/2020 | 47.52% | JMP Securities | $40 → $42 | Maintains | Market Outperform |
08/03/2020 | 1.86% | Morgan Stanley | $28 → $29 | Maintains | Underweight |
08/03/2020 | 19.42% | Credit Suisse | $32 → $34 | Maintains | Neutral |
06/23/2020 | 12.4% | Credit Suisse | → $32 | Initiates Coverage On | → Neutral |
05/06/2020 | 22.94% | Argus Research | $51 → $35 | Maintains | Buy |
05/04/2020 | -15.7% | UBS | $23 → $24 | Maintains | Neutral |
05/01/2020 | -15.7% | CFRA | $22 → $24 | Maintains | Sell |
04/24/2020 | -22.73% | CFRA | $46 → $22 | Downgrades | Hold → Sell |
04/09/2020 | 40.5% | JMP Securities | $50 → $40 | Maintains | Market Outperform |
04/09/2020 | -1.65% | Morgan Stanley | $39 → $28 | Maintains | Underweight |
03/25/2020 | -19.21% | UBS | $41 → $23 | Maintains | Neutral |
01/31/2020 | 61.57% | CFRA | $43 → $46 | Maintains | Hold |
01/27/2020 | 68.6% | Keefe, Bruyette & Woods | $40 → $48 | Upgrades | Market Perform → Outperform |
01/13/2020 | 61.57% | Buckingham Research | $40 → $46 | Maintains | Neutral |
01/06/2020 | — | Wolfe Research | Upgrades | Underperform → Peer Perform | |
11/20/2019 | 22.94% | Morgan Stanley | → $35 | Initiates Coverage On | → Underweight |
10/09/2019 | 40.5% | Buckingham Research | $41 → $40 | Maintains | Neutral |
07/11/2019 | 44.01% | Buckingham Research | $45 → $41 | Maintains | Neutral |
06/10/2019 | — | UBS | Downgrades | Buy → Neutral | |
04/11/2019 | — | B of A Securities | Downgrades | Buy → Neutral | |
11/06/2018 | 61.57% | Goldman Sachs | → $46 | Initiates Coverage On | → Neutral |
日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
---|---|---|---|---|---|
2023年10月27日 | 58.06% | 摩根士丹利 | $41→$45 | 維護 | 超重 |
2023年10月12日 | 44.01% | 摩根士丹利 | $42→$41 | 維護 | 超重 |
2023年10月10日 | 75.62% | JMP證券 | $53→$50 | 維護 | 市場表現強於大盤 |
10/03/2023 | 12.4% | 瑞銀集團 | $37→$32 | 維護 | 中性 |
09/26/2023 | 47.52% | 摩根士丹利 | $44→$42 | 維護 | 超重 |
2023/09/19 | 12.4% | 高盛 | $37→$32 | 評級下調 | 中性→銷售 |
07/31/2023 | 29.96% | 瑞銀集團 | $32→$37 | 維護 | 中性 |
07/14/2023 | 51.04% | 摩根士丹利 | $43→$43 | 重申 | 超重→超重 |
07/13/2023 | - | Keefe,Bruyette&Wood | 升級 | 表現遜於→市場表現 | |
07/12/2023 | 51.04% | 摩根士丹利 | $36→$43 | 升級 | 等重→超重 |
07/10/2023 | 86.16% | JMP證券 | →$53 | 重申 | 市場表現優於→市場表現 |
07/03/2023 | - | 沃爾夫研究 | 升級 | 表現不佳的→對等設備 | |
2023年05月22日 | 86.16% | JMP證券 | $53→$53 | 重申 | 市場表現優於→市場表現 |
05/01/2023 | 8.89% | Keefe,Bruyette&Wood | $34→$31 | 維護 | 表現不佳 |
04/12/2023 | 26.45% | 摩根士丹利 | $29→$36 | 升級 | 重量不足的→等重 |
2023年1月10日 | 86.16% | JMP證券 | $56→$53 | 維護 | 市場表現強於大盤 |
2022年10月31日 | 1.86% | 摩根士丹利 | $28→$29 | 維護 | 體重不足 |
08/04/2022 | 26.45% | 高盛 | $32→$36 | 維護 | 中性 |
07/18/2022 | 5.37% | 摩根士丹利 | $40→$30 | 評級下調 | 等重→減碼 |
07/13/2022 | 5.37% | Keefe,Bruyette&Wood | $38→$30 | 評級下調 | 市場表現→表現不佳 |
07/08/2022 | 54.55% | 派珀·桑德勒 | $45→$44 | 維護 | 超重 |
04/07/2022 | 58.06% | 派珀·桑德勒 | $49→$45 | 維護 | 超重 |
04/07/2022 | 96.7% | JMP證券 | $58→$56 | 維護 | 市場表現強於大盤 |
04/07/2022 | 36.99% | 沃爾夫研究 | →$39 | 評級下調 | 同行執行→表現不佳 |
03/09/2022 | 82.65% | 派珀·桑德勒 | $62→$52 | 維護 | 超重 |
03/08/2022 | 40.5% | 摩根士丹利 | →$40 | 評級下調 | 超重→等重 |
02/04/2022 | 72.11% | Keefe,Bruyette&Wood | $52→$49 | 評級下調 | 跑贏→市場表現 |
01/04/2022 | 51.04% | 瑞銀集團 | $47→$43 | 維護 | 中性 |
12/08/2021 | 93.19% | 摩根士丹利 | $61→$55 | 維護 | 超重 |
10/01/2021 | 103.72% | Keefe,Bruyette&Wood | $53→$58 | 升級 | 市場表現優於→ |
05/03/2021 | 72.11% | 瑞士信貸 | $50→$49 | 維護 | 中性 |
04/12/2021 | 75.62% | 瑞士信貸 | $49→$50 | 維護 | 中性 |
04/07/2021 | 114.26% | 摩根士丹利 | →$61 | 升級 | 等重→超重 |
2021/01/14 | 75.62% | Keefe,Bruyette&Wood | →$50 | 評級下調 | 跑贏→市場表現 |
12/16/2020 | 72.11% | 環球海港 | →$49 | 開始承保 | →購買 |
12/14/2020 | 82.65% | 摩根士丹利 | $39→$52 | 升級 | 重量不足的→等重 |
10/12/2020 | 36.99% | 摩根士丹利 | $29→$39 | 維護 | 體重不足 |
10/09/2020 | 47.52% | JMP證券 | $40→$42 | 維護 | 市場表現強於大盤 |
08/03/2020 | 1.86% | 摩根士丹利 | $28→$29 | 維護 | 體重不足 |
08/03/2020 | 19.42% | 瑞士信貸 | $32→$34 | 維護 | 中性 |
2020/06/23 | 12.4% | 瑞士信貸 | →$32 | 開始承保 | →中性 |
05/06/2020 | 22.94% | Argus研究 | $51→$35 | 維護 | 買 |
05/04/2020 | -15.7% | 瑞銀集團 | $23→$24 | 維護 | 中性 |
05/01/2020 | -15.7% | CFRA | $22→$24 | 維護 | 賣 |
04/24/2020 | -22.73% | CFRA | $46→$22 | 評級下調 | 持有→Sell |
04/09/2020 | 40.5% | JMP證券 | $50→$40 | 維護 | 市場表現強於大盤 |
04/09/2020 | -1.65% | 摩根士丹利 | $39→$28 | 維護 | 體重不足 |
03/25/2020 | -19.21% | 瑞銀集團 | $41→$23 | 維護 | 中性 |
2020/01/31 | 61.57% | CFRA | $43→$46 | 維護 | 保持 |
2020/01/27 | 68.6% | Keefe,Bruyette&Wood | $40→$48 | 升級 | 市場表現優於→ |
2020/01/13 | 61.57% | 白金漢研究 | $40→$46 | 維護 | 中性 |
01/06/2020 | - | 沃爾夫研究 | 升級 | 表現不佳的→對等設備 | |
2019年11月20日 | 22.94% | 摩根士丹利 | →$35 | 開始承保 | →減持 |
2019年10月09日 | 40.5% | 白金漢研究 | $41→$40 | 維護 | 中性 |
2019年07月11日 | 44.01% | 白金漢研究 | $45→$41 | 維護 | 中性 |
2019年06月10日 | - | 瑞銀集團 | 評級下調 | 購買→中性 | |
2019年4月11日 | - | B of A證券 | 評級下調 | 購買→中性 | |
2018/06/11 | 61.57% | 高盛 | →$46 | 開始承保 | →中性 |
What is the target price for Lazard (LAZ)?
拉扎德(Lazard)的目標價是多少?
The latest price target for Lazard (NYSE: LAZ) was reported by Morgan Stanley on October 27, 2023. The analyst firm set a price target for $45.00 expecting LAZ to rise to within 12 months (a possible 58.06% upside). 17 analyst firms have reported ratings in the last year.
Lazard(紐約證券交易所代碼:LAZ)的最新目標價由摩根士丹利於2023年10月27日報道。這家分析公司將目標價定為45.00美元,預計LAZ將在12個月內升至(可能上漲58.06%)。過去一年,17家分析公司公佈了評級。
What is the most recent analyst rating for Lazard (LAZ)?
Lazard(LAZ)的最新分析師評級是多少?
The latest analyst rating for Lazard (NYSE: LAZ) was provided by Morgan Stanley, and Lazard maintained their overweight rating.
分析師對Lazard(紐約證券交易所代碼:LAZ)的最新評級由摩根士丹利提供,Lazard維持其增持評級。
When is the next analyst rating going to be posted or updated for Lazard (LAZ)?
Lazard(LAZ)的下一次分析師評級將於何時發佈或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Lazard, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Lazard was filed on October 27, 2023 so you should expect the next rating to be made available sometime around October 27, 2024.
分析師在進行了廣泛的研究後得出了股票評級,其中包括查閱公共財務報表,與Lazard的高管和客戶交談,以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次,所以你每年應該會得到每家公司每家公司的4個評級。Lazard的上一次評級是在2023年10月27日提交的,所以你應該預計下一次評級將在2024年10月27日左右提供。
Is the Analyst Rating Lazard (LAZ) correct?
分析師評級Lazard(LAZ)正確嗎?
While ratings are subjective and will change, the latest Lazard (LAZ) rating was a maintained with a price target of $41.00 to $45.00. The current price Lazard (LAZ) is trading at is $28.47, which is out of the analyst's predicted range.
雖然評級是主觀的,並將發生變化,但最新的Lazard(LAZ)評級維持不變,目標價在41.00美元至45.00美元之間。Lazard(LAZ)目前的交易價格為28.47美元,超出了分析師的預測區間。